Product Information
FARXIGA 5 MG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $12.0755 per EA under NDC 00310620530. Its NADAC has been published 596 times since Feb 18, 2015.
FDA first approved this application on Jan 8, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310620530
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DAPAGLIFLOZIN PROPANEDIOLApproval Type
New Drug (NDA)
FDA Application
NDA202293FDA Approved
1/8/2014
TE Code
AB
On Market Since
1/14/2008
Pharmacological Classes
Price Statistics
The NADAC for FARXIGA 5 MG TABLET has been published 596 times since Feb 18, 2015, and over the history we have for it it has risen 19.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.0755 per EA |
|---|---|
| All-time high | $19.1785 (May 14, 2025) |
| All-time low | $10.0917 (Feb 18, 2015) |
| 52-week high | $19.1591 |
| 52-week low | $12.0700 |
| Median price | $16.2227 |
| Average price | $15.7703 |
| Largest weekly change | -37.0% (Jan 14, 2026) |
| Weeks tracked | 596 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FARXIGA 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FARXIGA 5 MG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $12.0755 per EA (NDC 00310620530), effective Aug 19, 2026.
How has the price of FARXIGA 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for FARXIGA 5 MG TABLET has risen 19.7%. It has been tracked across 596 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for FARXIGA 5 MG TABLET?
Since Feb 18, 2015, the NADAC for FARXIGA 5 MG TABLET has ranged from a low of $10.0917 (Feb 18, 2015) to a high of $19.1785 (May 14, 2025), with a median of $16.2227 per EA.
Are there cheaper alternatives to FARXIGA 5 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DAPAGLIFLOZIN 5 MG TABLET, is $0.1845 per EA — about 98% below FARXIGA 5 MG TABLET.
Who manufactures FARXIGA 5 MG TABLET?
FARXIGA 5 MG TABLET (NDC 00310620530) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.